Cargando…
Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer
Breast cancers can recur after removal of the primary tumor and treatment to eliminate remaining tumor cells. Recurrence may occur after long periods of time during which there are no clinical symptoms. Tumor cell dormancy may explain these prolonged periods of asymptomatic residual disease and trea...
Autores principales: | Kim, Ryung S., Avivar-Valderas, Alvaro, Estrada, Yeriel, Bragado, Paloma, Sosa, Maria Soledad, Aguirre-Ghiso, Julio A., Segall, Jeffrey E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329481/ https://www.ncbi.nlm.nih.gov/pubmed/22530051 http://dx.doi.org/10.1371/journal.pone.0035569 |
Ejemplares similares
-
Analysis of Marker-Defined HNSCC Subpopulations Reveals a Dynamic Regulation of Tumor Initiating Properties
por: Bragado, Paloma, et al.
Publicado: (2012) -
A human tRNA methyltransferase 9-like protein prevents tumour growth by regulating LIN9 and HIF1-α
por: Begley, Ulrike, et al.
Publicado: (2013) -
NR2F1 controls tumor cell dormancy via SOX9 and RARβ driven quiescence programs
por: Sosa, Maria Soledad, et al.
Publicado: (2015) -
TGFβ2 dictates disseminated tumour cell fate in target organs through TGFβ-RIII and p38α/β signalling
por: Bragado, Paloma, et al.
Publicado: (2013) -
Inhibition of eIF2α dephosphorylation inhibits ErbB2-induced deregulation of mammary acinar morphogenesis
por: Sequeira, Sharon J, et al.
Publicado: (2009)